In DN, hyperglycemia induces increased ROS production from sources such as NADPH oxidases and mitochondrial dysfunction, leading to pathological changes, including glomerulosclerosis and tubulointerstitial fibrosis [35,36,37]. Here, FMO5 is linked to Hyperglycemia.